Skip to main content
. 2017 Mar 10;8(15):25582–25598. doi: 10.18632/oncotarget.16106

Figure 4. SOX-2 immunostaining analysis of glioma cell lines.

Figure 4

(A) Percentage (%) of SOX-2 positive cells in glioma cell lines maintained both in St-M (white bars) and GSC-M (black bars) evaluated by cytofluorimetric analysis. Data are presented as the mean values of one representative out of two independent experiments in duplicates ± SD. (B)Values of Median Fluorescence Intensity (MFI) of SOX-2 in glioma cell lines maintained both in St-M and GSC-M. Data are from one representative out of two independent experiments in duplicates ± SD.